This webinar will cover a practical approach to managing heart failure patients and when to consider an SGLT2i. This will include a brief overview of the evidence of SGLT2i’s in heart failure and case-based discussions with Q+A.
Jo Bateman, Lead Cardiology Pharmacist and Deputy Clinical Services Manager, Countess of Chester Hospital
Paul Forsyth, MRPharmS (Consultant), Lead Pharmacist- Clinical Cardiology, NHS Greater Glasgow and Clyde
This webinar is ideal for pharmacists and other healthcare practitioners with an interest in Heart Failure working in Primary or Secondary care.
The aim of this webinar is to give participants a greater understanding of the practical application of initiating an SGLT2i in Heart Failure and greater understanding of the evidence for its use in both HF-rEF, HF-mrEF and HF-pEF.
At the end of this webinar, participants should be able to:
- Discuss the evidence behind SGLT2i’s in heart failure with reduced ejection fraction (EF)
- Discuss the evidence for SGLT2i’s in heart failure with mid-range EF and preserved EF
- Describe practical aspects to initiating an SGLT2i – when and how
Delegates will be expected to undertake a small amount of pre reading before attending the webinar.